Bristol-Myers Squibb will acquire Medarex, a biopharma focused on antibody-based therapeutics for the
treatment life-threatening or debilitating diseases, for $2.4 billion. The deal
includes full ownership of ipilimumab, a melanoma treatment in phase 3, which
BMS called a potentially “important contributor to…future growth,” in a statement.
Physicians Interactive has acquired Skyscape, a mobile health information
provider. Skyscape's user base exceeds one million medical practitioners,
according to a release. Terms of the deal were not disclosed.